Neurocrine Bioscience buy Truist Financial Co.
Start price
08.01.26
/
50%
€116.75
Target price
08.01.27
€144.77
Performance (%)
-4.11%
Price
09.03.26
€111.95
Summary
This prediction is currently active. With a performance of -4.11%, the BUY prediction for Neurocrine Bioscience by Truist_Financial_Co_ is down slightly. This prediction currently runs until 08.01.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -1.104% | -1.104% |
| iShares Core DAX® | -3.520% | -4.987% |
| iShares Nasdaq 100 | 0.261% | 1.102% |
| iShares Nikkei 225® | -4.953% | -3.352% |
| iShares S&P 500 | -0.823% | -0.042% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Truist Financial Corporation from $172.00 to $169.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
3.80%
09.03.26
09.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
-6.20%
09.03.26
09.03.26